Not Approved. The proposal was sent back for revision with an eye to performing it on fewer patients and therefore using fewer clips and reducing cost.
EMERGENCY HEART FAILURE MORTALITY RISK GRADE SCORE FOR HEART FAILURE
The Pitch: To create a Web-based scoring system that helps indicate which heart failure patients are at high risk of death if not admitted to hospital. In year two, it would be developed as a smartphone app. Patients admitted for heart failure are normally kept in hospital between three and 14 days. This device can help determine who needs to be kept in hospital and who can be fast tracked through a new outpatient treatment clinic.
The Device: A computer-based algorithm created by physicians at the Peter Munk Cardiac Centre that provides a score based on a patient’s vital signs and condition. Health-care providers, usually in emergency rooms, enter information on a website that when analyzed by a computer model, produces a score. That, along with clinical judgment, helps determine if a patient should be admitted.
The Cost: $30,000. Cost per patient: trivial. [A new clinic for rapid out-patient care at an as-yet-undefined cost would require additional funds.]/p>
The Grade: All As.
Approved for Web development.
Innovators from many backgrounds
The 13-member Peter Munk Cardiac Centre Innovation Committee panel has five lay people with backgrounds in including health-care consulting, real-estate development and entrepreneurial business development. [One lay person did not attend the last meeting] In addition, there are physicians, surgeons, a research fellow, a hospital administrator and a nurse.
Jordan Dermer is managing partner for CD Capital, a Toronto-based real estate development firm.
Angela Feldman is executive vice-president of Camrost-Felcorp, a Greater Toronto Area real-estate firm.
Jeff Rubenstein is chief executive officer of Export Packers Company Limited, one of the largest privately owned food companies in Canada.
Joelle Faulkner, 28, is a Rhodes and Fulbright Scholar, who is an entrepreneur in medical devices and agriculture.
Follow us on Twitter: